Mészáros, M., Phan, T. H. M., Vigh, J. P., Porkoláb, G., Kocsis, A., Szecskó, A., . . . Deli, M. A. Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood–brain barrier model. BMC.
Chicago Style (17th ed.) CitationMészáros, Mária, et al. Alanine and Glutathione Targeting of Dopamine- or Ibuprofen-coupled Polypeptide Nanocarriers Increases Both Crossing and Protective Effects on a Blood–brain Barrier Model. BMC.
MLA (9th ed.) CitationMészáros, Mária, et al. Alanine and Glutathione Targeting of Dopamine- or Ibuprofen-coupled Polypeptide Nanocarriers Increases Both Crossing and Protective Effects on a Blood–brain Barrier Model. BMC.
Warning: These citations may not always be 100% accurate.